MONDAY, March 17, 2025 (HealthDay News) — For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he is the first person in New York to be cured of the disease. “Sickle cell was like a blockade for me,Continue Reading
TUESDAY, March 4, 2025 (HealthDay News) — Continuous blood glucose monitors have been promoted as potentially life-changing for people with diabetes — allowing real-time updates on blood sugar levels without the need for repeated finger pricks. But a new small-scale study suggests these devices might not be as accurate asContinue Reading
FRIDAY, Feb. 21, 2025 (HealthDay News) — One of the NBA’s most exciting rising stars will spend the rest of the 2024-2025 season on the bench. Victor Wembanyama, the San Antonio Spurs’ 7-foot 3-inch phenom, was sidelined after doctors discovered a dangerous blood clot in his right shoulder, the leagueContinue Reading
Hardware and software changes, updates, and configurations can result in undelivered critical safety alertsContinue Reading
FRIDAY, Jan. 24, 2025 (HealthDay News) — People with sickle cell disease often struggle with memory, focus, learning and problem solving, setting them back in school and the workplace. That could be because their brains are older than expected for their age, a new study published recently in JAMA NetworkContinue Reading
FRIDAY, Dec. 27, 2024 (HealthDay News) — A blood transfusion following a heart attack could be a life-saving measure for patients with anemia. A new evidence review published in the journal NEJM Evidence shows anemic patients had a slightly lower risk of death within six months of a heart attackContinue Reading
TUESDAY, Nov. 19, 2024 (HealthDay News) — Japanese researchers say they have found a pill that works as well as existing medication to prevent blood clots after heart valve surgery, with fewer trips to the doctor. Unlike warfarin, the standard treatment, edoxaban does not require regular monitoring of blood clottingContinue Reading
THURSDAY, Sept. 25, 2024 (HealthDay News) — A new gene therapy approved earlier this year can serve as a sustainable single-dose treatment for people with hemophilia B, newly published clinical trial data shows. People with hemophilia B saw their bleeding episodes drop by an average 71% following a single infusionContinue Reading
FRIDAY, Sept. 20, 2024 (HealthDay News) — Stroke rates continue to rise among adults and children living with sickle cell disease, despite new standards of care meant to lower their risk, a new study finds. People with sickle cell are vulnerable to strokes caused by a blood vessel to theContinue Reading
MONDAY, Aug. 19, 2024 (HealthDay News) — Iron deficiency isn’t being effectively treated in the United States, with low iron levels persisting for years in most patients, a new study finds. Almost 3 of 5 (58%) patients with iron deficiency still had low iron levels three years after their diagnosis,Continue Reading